Parameter
| Biomarker | FBG | Full name | Fasting blood glucose | Molecular Type | Metabolites |
|---|---|---|---|---|---|
| Molecular Formula | C₆H₁₂O₆ | Molecular Weight | 180.16 | Core Functional Dimensions | Diagnosis and surveillance |
| Disease | Metabolic Syndrome | Disease Subtypes | / | ||
| Organ | Pancreas/Liver | Test Sample / Technology Platform | Serum/plasma (glucose oxidase method, hexokinase method) | ||
| Pathobiological Mechanisms | Insulin resistance leads to impaired glucose uptake and utilization and imbalance of blood glucose homeostasis | ||||
| Clinical Availability Status | Clinical routine application: diagnostic core index (≥100 mg/dL), combined with other indicators to diagnose MetS | ||||
| Notes and Dynamics | Can promote blood glucose metabolic abnormalities associated with HbA1c evaluation accuracy | ||||